Metastatic Colorectal Cancer

Stop sign

Pharma

Bristol Myers scraps Opdualag trial in colorectal cancer

The company opted to cut the phase 3 study after an analysis found that the trial was unlikely to achieve its primary endpoints.

Zoey Becker Dec 18, 2023 10:50am

Takeda

FDA signs off on Takeda's colorectal cancer drug Fruzaqla

Nov 9, 2023 10:54am

FDA

Seagen's Tukysa picks up FDA priority review in Herceptin combo

Sep 20, 2022 10:59am